Inhibitory Activity of Levofloxacin against MDR Staphylococcus aureus and Pseudomonas aeruginosa Clinical Isolates

Author:

Nathalie Lisa,Alimsardjono Lindawati,Isnaeni Isnaeni

Abstract

Introduction: Staphylococcus  aureus  and  Pseudomonas  aeruginosa  are the most dangerous  and important species among  their genus.  These  bacteria  are often  resistant  to  many  classes  of antimicrobial  agents;  which  make difficulties in selecting appropriate drug to treat infections. Multidrug-resistance occurs readily in hospitals for which antimicrobials  agents  were   used  widely. Objective: The  aims  of  this  study  was  to  determine  minimum  inhibitory concentration  (MIC) and  minimum bacterial  concentration  (MBC) of levofloxacin  against 22 multidrug  resistant- clinical (MDR) strains of Staphylococcus aureus and Pseudomonas aeruginosa isolated from patients pus and urine in hospital. Methods: Determination of the MIC was performed by macro-dilution broth assay as recommended by Clinical and Laboratory Standards Institute (CLSI), while the MBC was determined one-step further after the MIC determination. Results: It was found that MIC of the levofloxacin were (0.3 ± 0.0) - >0.5 µg/mL and (0.2 ± 0.1) - (1.0 ±0.0)µg/mL against S. aureus from pus and urine, respectively.  In addition, higher MICs were yielded against P. aeruginosa, (1.0 ± 0.0) - >8.0 µg/mL and (0.7 ± 0.3) - (3.0 ± 1.2) µg/mL for pus and urine isolates respectively. Similar to MICs, the MBCs against P. aeruginosa were higher than S. aureus, (0.6 ± 0.0) - > 4.0 µg/mL and (0.3 ± 0.0) - >8.0 µg/mL isolated from pus and urine respectively, (2.0 ± 0.6) - > 8.0 µg/mL and (3.0 ± 1.2) - >7.0 µg/mL against P. aeruginosa from pus and urine respectively. Conclusion: The levofloxacin was still susceptible as bacteriostatic against isolates from both body fluids, but not bactericidal towards all isolates.

Publisher

Universitas Airlangga

Reference26 articles.

1. Bambeke, F. V., Gllupeczynski, Y., Plésiat, P., Pechère, J. C. & Tulkens, P. M. (2003). Antibiotic Efflux Pumps in Procaryotic Cells: Occurrence, Impact on Resistance and Strategies for the Future of Antimicrobial Therapy. Journal of Antimicrobial Chemotherapy; 51; 1055-1065.

2. Brooks, G. F., Butel, J. S. & Morse, S. A. (2001). Jawetz, Melnick and Adelberg's Medical Microbiology. 22th ed. Boston: Appleton & Lange.

3. Clinical and Laboratory Standards Institute. (2006). Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically - Seventh Edition; Approved standard M7-A7. Wayne, PA: CLSI.

4. Clinical and Laboratory Standards Institute. (2006). Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. Wayne, PA: CLSI.

5. Effective Antibiotic-Resistance Control Strategies;Cunha;Lancet 3537 1307-1308,2001

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3